Drugs / Hengge Liejing
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07198516 | Nov 2025 → Sep 2026 overdue | NAFLD1, type 2 diabetes mellitus | Fujian Medical University Union Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hengge Liejing | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07198516 ↗ |
| Route | Oral | “taken orally in the morning” NCT07198516 ↗ |